English
简体中文
繁體中文
English
Filipino
हिन्दी
Hmong
Bahasa Indonesia
日本語
Basa Jawa
한국어
ພາສາລາວ
Bahasa Melayu
മലയാളം
ဗမာစာ
سنڌي
தமிழ்
ไทย
Tiếng Việt
Afrikaans
Shqip
العربية
አማርኛ
Հայերեն
Azərbaycan dili
Euskara
Беларуская мова
বাংলা
Bosanski
Български
Català
Cebuano
Chichewa
Corsu
Italiano
Hrvatski
Čeština
Dansk
Nederlands
Esperanto
Eesti
Suomi
Frysk
Galego
ქართული
Ελληνικά
ગુજરાતી
Kreyol ayisyen
Deutsch
Français
Harshen Hausa
Ōlelo Hawaiʻi
עִבְרִית
Magyar
Íslenska
Igbo
Gaeilge
ಕನ್ನಡ
Қазақ тілі
ភាសាខ្មែរ
كوردی
Кыргызча
Latin
Latviešu valoda
Lietuvių kalba
Lëtzebuergesch
Македонски јазик
Malagasy
Maltese
Te Reo Māori
मराठी
Монгол
नेपाली
Norsk bokmål
پښتو
فارسی
Polski
Português
ਪੰਜਾਬੀ
Română
Русский
Samoan
Gàidhlig
Српски језик
Sesotho
Shona
සිංහල
Slovenčina
Slovenščina
Afsoomaali
Español
Basa Sunda
Kiswahili
Svenska
Тоҷикӣ
తెలుగు
Türkçe
Українська
اردو
O‘zbekcha
Cymraeg
isiXhosa
יידיש
Yorùbá
ZuluGERMANY: medmix, a prominent player in high-precision delivery devices for the dental sector, has achieved a significant legal victory in a patent infringement case against the Kettenbach/Xinial dental mixing system.
The Düsseldorf Higher Regional Court (OLG Düsseldorf) recently ruled in favor of medmix, affirming that the Kettenbach/Xinial system infringes upon medmix’s European Patent EP2485852B1.
Enforceable Injunction Issued
The judgment, announced on February 1, 2024, entails a provisional enforceable injunction against Kettenbach GmbH & Co. KG and XINIAL Systems GmbH & Co. KG, prohibiting them from manufacturing, offering, or selling the infringing dental mixing system in or from Germany.
Additionally, the court mandated Kettenbach/Xinial to provide a detailed account of the infringing acts, recall the products from commercial customers, and destroy the infringing items in their possession.
Despite the court’s decision, Kettenbach/Xinial has lodged a complaint against the denial of leave to appeal. However, an appeal on points of law was not permitted by the Düsseldorf court. Furthermore, medmix’s European Patent EP2485852B1’s validity has been upheld by the European Patent Office and the German Federal Patent Court.
Ongoing Litigation in the US
In addition to the German case, medmix has initiated legal action in New York against Kettenbach/Xinial, addressing false advertising and trademark infringement claims. The trial is anticipated to commence in early 2025. Meanwhile, Xinial has filed an invalidity case against medmix’s US patent at the US Patent and Trademark Office, which is subject to an ongoing appeal by medmix.
About medmix
medmix Switzerland Ltd. operates globally, specializing in static mixing tips, cartridges, and dispensing devices for the dental sector. With over 900 active patents, medmix is renowned for its dedication to innovation and technological advancement. Headquartered in Baar, Switzerland, medmix boasts 14 production sites worldwide and a team of approximately 2,700 employees committed to delivering uncompromising quality.
The information and viewpoints presented in the above news piece or article do not necessarily reflect the official stance or policy of Dental Resource Asia or the DRA Journal. While we strive to ensure the accuracy of our content, Dental Resource Asia (DRA) or DRA Journal cannot guarantee the constant correctness, comprehensiveness, or timeliness of all the information contained within this website or journal.
Please be aware that all product details, product specifications, and data on this website or journal may be modified without prior notice in order to enhance reliability, functionality, design, or for other reasons.
The content contributed by our bloggers or authors represents their personal opinions and is not intended to defame or discredit any religion, ethnic group, club, organisation, company, individual, or any entity or individual.